Jerry A. Shields, MD is a world-renowned ophthalmologist and Director Emeritus of the Ocular Oncology Service at Wills Eye Hospital. He received his medical degree from University of Michigan Medical School and completed his residency at Wills Eye Hospital.
After residency, Dr. Shields trained as a retina fellow at Wills Eye followed by a fellowship in ophthalmic pathology at the Armed Forces Institute of Pathology. He went on to become one of the first pioneers in the use of radioactive plaques for the treatment of intraocular tumors.
Dr. Shields has trained more than 100 fellows from all parts of the world in ocular oncology. He has authored or co-authored more than 1,300 articles and 550 textbook chapters for a total of nearly 1,900 scientific publications. He has also authored or co-authored 13 textbooks and has given numerous talks and prestigious named lectures throughout the world.
Dr. Shields has won more than 40 awards. In 2012, the Asia Pacific Academy of Ophthalmology established the Jerry A. Shields, MD Lecture to be presented annually at their Congress. In March of 2013 Dr. Shields was awarded the National Physician of the Year Award for Clinical Excellence (top doctor in America) by Castle Connelly Medical, Ltd., New York, N.Y.
Dr. Shields has served on editorial boards in the United States, Great Britain, Germany and Denmark. He has been president of the Macula Society and was the first president of the International Society of Ocular Oncology.
Wills Eye Hospital, Vitreoretinal Surgery – 1972, 1970; Armed Forces Institute of Pathology, Ophthalmic Pathology – 1971
Wills Eye Hospital – 1970
University of Michigan – 1964
Murray State University – 1960
Professor of Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson University
Honors and Awards
American Board of Ophthalmology – 1972
Castle Connolly “National Physician of the Year” 2013 Philadelphia magazine “Top Doctors” 2011, 2012, 2013, 2014, 2015, 2016, 2017 Castle Connolly “America’s Top Doctors” 2011-2017
Areas of Interest:
Ocular Oncology Service in 1974. He has had long interest in eye cancer and has published over 800 articles on various subjects. His main interest is in the subject of choroidal melanoma and retinoblastoma. He pioneered new therapies and was instrumental in popularizing plaque raiotherapy for choroidal melanoma to save the patients eye. Along with the other members of the Ocular Oncology Service, he has continued to be a leader in eye cancer research nationally and internationally. He has published numerous textbooks and chapters on ocular tumors and is presently the President of the International Society of Ocular Oncology.
Jerry A. Shields, MD, Director of the Wills Eye Oncology Service, received the 2014 Laureate Award, the American Academy of Ophthalmology’s highest honor.